Dapagliflozin is a medication used primarily to manage type 2 diabetes. It belongs to a class of drugs known as SGLT2 inhibitors, which work by helping the kidneys remove excess sugar from the bloodstream through urine. This can help lower blood sugar levels and improve overall glycemic control. In addition to its use in diabetes, dapagliflozin has also been studied for its potential benefits in heart failure and chronic kidney disease. By reducing the workload on the heart and improving kidney function, it may provide additional health benefits for patients with these conditions.